# FDA 483 - Central California Blood Center/ Clovis Donor Center - December 11, 2024

Source: https://www.keypedia.com/records/483/central-california-blood-center-clovis-donor-center/6b7fe1bc-87cb-4d6e-9858-0f81634464d9

> FDA 483 for Central California Blood Center/ Clovis Donor Center on December 11, 2024. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Central California Blood Center/ Clovis Donor Center
- Inspection Date: 2024-12-11
- Product Type: biologics
- Office Name: Division of Human and Animal Food Operations - West V
- Summary: An FDA inspection of Central California Blood Center/Clovis Donor Center in Clovis, CA, identified two significant observations. The facility failed to provide adequate space for the orderly and clean storage of blood and blood components, leading to potential contamination risks. Additionally, phlebotomists were observed not consistently following written standard operating procedures for inverting sample tubes during blood collection, which could affect sample integrity.

## Related Documents

- [483 - 2024-12-11](https://www.keypedia.com/records/483/central-california-blood-center-clovis-donor-center/985280d7-da56-496e-b038-ce80ea2e3b8c)

## Related Officers

- [Conor J. Mccarron](https://www.keypedia.com/people/conor-j-mccarron/280401e4-b080-4ba8-ab35-d3b16e91c2b1)

Company: https://www.keypedia.com/companies/central-california-blood-center-clovis-donor-center/fa5794b3-750f-490c-8af5-8af9006a647f

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-v/0f4dd01e-8e8a-4336-9abe-ce8b3d309e8b